Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation
نویسندگان
چکیده
منابع مشابه
The Preventative Effects of Recombinant Thrombomodulin on Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation (HSCT) involves specific serious transplant-related complications [1,2], and recovery from these complications is vital for achieving a successful HSCT outcome. Therefore, taking steps to mitigate coagulationand Graft-Versus Host Disease (GVHD)-related complications following HSCT is very important. Several interactions between coagulation-related blood c...
متن کاملMalakoplakia After Allogeneic Hematopoietic Stem Cell Transplantation.
A 32-year-old woman named A.C. was diagnosed five years ago with stage IIIB nodular sclerosing Hodgkin lymphoma (HL). Following initial chemotherapy, she had refractory disease as evidenced by hypermetabolic activity on positron-emission tomography (PET) scan. A.C. was treated with a short course of salvage chemotherapy, stem cell collection, and autologous HSCT about 11 months after initial di...
متن کاملSolid cancers after allogeneic hematopoietic cell transplantation.
Transplant recipients have been reported to have an increased risk of solid cancers but most studies are small and have limited ability to evaluate the interaction of host, disease, and treatment-related factors. In the largest study to date to evaluate risk factors for solid cancers, we studied a multi-institutional cohort of 28 874 allogeneic transplant recipients with 189 solid malignancies....
متن کاملOptimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation.
OBJECTIVE Allogeneic hematopoietic stem cell transplantation (HSCT) is associated with prolonged anemia caused by defective erythropoietin (Epo) production. We enrolled 34 recipients of an allogeneic HSCT in three consecutive trials to determine the optimal utilization of recombinant human erythropoietin (rhEpo) therapy in this setting. MATERIALS AND METHODS In the first trial (n = 7), rhEpo ...
متن کاملDyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management.
Currently, approximately 15,000 to 20,000 patients undergo allogeneic hematopoietic stem cell transplantation (HSCT) annually throughout the world, with the number of long-term survivors increasing rapidly. In long-term follow-up after transplantation, the focus of care moves beyond cure of the original disease to the identification and treatment of late effects after HSCT. One of the more seri...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood Advances
سال: 2021
ISSN: 2473-9529,2473-9537
DOI: 10.1182/bloodadvances.2020003749